loader image
Monday, December 11, 2023
42.5 F
We Welcome your Press Release
- Advertisement -

Begley Contributes to Global Epilepsy Projects

Translate to Spanish or other 102 languages!

Charles E. Begley
Charles E. Begley

Mega Doctor News

- Advertisement -

As originally published in Mega Doctor News newsprint edition August 2018

Houston, Texas – Charles E. Begley, Ph.D., professor in the Department of Management, Policy and Community Health at UTHealth School of Public Health in Houston, has been invited to work on the Global Epilepsy Report sponsored by the World Health Organization, International League Against Epilepsy and the International Bureau for Epilepsy. Begley will serve on the editorial board for the report and as lead author of the chapter on health care response.

The purpose of the report is to raise awareness of the global burden of the disease and to identify and support possible approaches to enhance access to affordable epilepsy care and services. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally, according to the World Health Organization. Three-fourths of people with epilepsy living in low- and middle- income countries do not get the treatment they need.

- Advertisement -

“This report will provide background information and analysis leading to a global action plan for epilepsy (similar to existing plans for dementia, suicide, aging, and non-communicable diseases) with milestones, indicators, and targets to facilitate advocacy,” Begley says.

Begley also has been appointed co-chair of the International League Against Epilepsy’s Task Force on the Cost of Epilepsy. During the next four years, the task force will develop evidence-based estimates of the direct and indirect cost of epilepsy at the country, region and global levels based on reviews of the international cost literature and cost modeling.

Begley co-directs the Center for Health Services Research at UTHealth School of Public Health, which conducts research and provides technical assistance and training in the organization, financing, and outcomes of health services, systems, and policies. He has investigated the social and economic impact of epilepsy since 1994.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.

High Demand for Health Care Careers In The RGV

"Health care is a top priority for STC, we continue to exert all of our efforts and resources to provide students the best opportunities to succeed through a wide array of certificates and degrees," said STC President Ricardo J. Solis, Ph.D.

DHR Health Welcomes Family Medicine Physician, Dr. Ivan Garcia

In his new role at DHR Health as a practitioner in family medicine, Dr. Garcia’s responsibilities encompass providing patient health assessments and vital health screenings and diagnosing and managing acute and chronic conditions.

President Matt Wolthoff Celebrates the Opening of New Driscoll Quick Care Clinic in Edinburg, TX

This clinic represents Driscoll’s second Quick Care facility in the Valley and is strategically situated next to the soon-to-open Driscoll Children’s Hospital Rio Grande Valley.
- Advertisement -